Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
Ferovinum
start up
United Kingdom
- London
- 24/09/2024
- Series A
- $23,407,037
Ferovinum is a working capital platform that provides wine and spirits businesses with the ability to convert their inventories into an 'on-demand' service.
The platform enables our clients to finance growth, increase profitability and reduce risk. It also provides our capital providers with the ability to deploy capital in a more efficient and risk-managed way than bilateral secured lending.
- Industry Financial Services
- Website https://www.ferovinum.com/
- LinkedIn https://www.linkedin.com/company/ferovinum/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)